These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 21593735)
21. Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome. Laika B; Leucht S; Heres S; Schneider H; Steimer W Pharmacogenomics J; 2010 Feb; 10(1):20-9. PubMed ID: 19636338 [TBL] [Abstract][Full Text] [Related]
22. Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study. Pavanello S; Fedeli U; Mastrangelo G; Rota F; Overvad K; Raaschou-Nielsen O; Tjønneland A; Vogel U Cancer Genet; 2012 Jun; 205(6):278-84. PubMed ID: 22749033 [TBL] [Abstract][Full Text] [Related]
23. Frequencies of four genetic polymorphisms in the CYP1A2 gene in Turkish population. Bilgen T; Tosun O; Luleci G; Keser I Genetika; 2008 Aug; 44(8):1133-6. PubMed ID: 18825963 [TBL] [Abstract][Full Text] [Related]
24. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers. Wang L; Hu Z; Deng X; Wang Y; Zhang Z; Cheng ZN Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):257-63. PubMed ID: 23167834 [TBL] [Abstract][Full Text] [Related]
25. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Le Marchand L; Hankin JH; Wilkens LR; Pierce LM; Franke A; Kolonel LN; Seifried A; Custer LJ; Chang W; Lum-Jones A; Donlon T Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1259-66. PubMed ID: 11751443 [TBL] [Abstract][Full Text] [Related]
26. Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure. Söderberg MM; Haslemo T; Molden E; Dahl ML Pharmacogenet Genomics; 2013 May; 23(5):279-85. PubMed ID: 23492908 [TBL] [Abstract][Full Text] [Related]
27. Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism. Djordjevic N; Ghotbi R; Jankovic S; Aklillu E Eur J Clin Pharmacol; 2010 Jul; 66(7):697-703. PubMed ID: 20390257 [TBL] [Abstract][Full Text] [Related]
29. CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population. B'chir F; Pavanello S; Knani J; Boughattas S; Arnaud MJ; Saguem S Life Sci; 2009 May; 84(21-22):779-84. PubMed ID: 19332078 [TBL] [Abstract][Full Text] [Related]
30. Development of a high throughput single nucleotide polymorphism screening method for the cytochrome P450 1A2 polymorphisms CYP1A2*1C and CYP1A2*1F: are they useful as predictive markers in mental disorders? Klemm M; Eidens M; Lorenz M; Prause S; Weise A; Dahmen N; Forst T; Pfützner A Clin Lab; 2010; 56(9-10):473-80. PubMed ID: 21086794 [TBL] [Abstract][Full Text] [Related]
31. [Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan]. Korytina GF; Akhmadishina LZ; Kochetova OV; Zagidullin ShZ; Viktorova TV Mol Biol (Mosk); 2008; 42(1):32-41. PubMed ID: 18389617 [TBL] [Abstract][Full Text] [Related]
32. Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia. Tay JK; Tan CH; Chong SA; Tan EC Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1297-302. PubMed ID: 17611010 [TBL] [Abstract][Full Text] [Related]
33. The CYP1A2-164A-->C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans. Moonen H; Engels L; Kleinjans J; Kok Td Cancer Lett; 2005 Nov; 229(1):25-31. PubMed ID: 16157215 [TBL] [Abstract][Full Text] [Related]
34. Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin. Härtter S; Korhonen T; Lundgren S; Rane A; Tolonen A; Turpeinen M; Laine K Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):300-4. PubMed ID: 17040215 [TBL] [Abstract][Full Text] [Related]
35. Interaction between CYP1A2-T2467DELT polymorphism and smoking in adenocarcinoma and squamous cell carcinoma of the lung. Pavanello S; B'chir F; Pulliero A; Saguem S; Ben Fraj R; El Aziz Hayouni A; Clonfero E; Mastrangelo G Lung Cancer; 2007 Sep; 57(3):266-72. PubMed ID: 17509724 [TBL] [Abstract][Full Text] [Related]
36. Assessment of CYP1A2 activity in clinical practice: why, how, and when? Faber MS; Jetter A; Fuhr U Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):125-34. PubMed ID: 16128905 [TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Sachse C; Bhambra U; Smith G; Lightfoot TJ; Barrett JH; Scollay J; Garner RC; Boobis AR; Wolf CR; Gooderham NJ; Br J Clin Pharmacol; 2003 Jan; 55(1):68-76. PubMed ID: 12534642 [TBL] [Abstract][Full Text] [Related]
38. Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats. Chen L; Bondoc FY; Lee MJ; Hussin AH; Thomas PE; Yang CS Drug Metab Dispos; 1996 May; 24(5):529-33. PubMed ID: 8723732 [TBL] [Abstract][Full Text] [Related]
39. Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2. Han XM; Ou-Yang DS; Lu PX; Jiang CH; Shu Y; Chen XP; Tan ZR; Zhou HH Pharmacogenetics; 2001 Jul; 11(5):429-35. PubMed ID: 11470995 [TBL] [Abstract][Full Text] [Related]
40. Smoking but not homozygosity for CYP1A2 g-163A allelic variant leads to earlier disease onset in patients with sporadic porphyria cutanea tarda. Fontanellas A; Martínez-Fresno M; Garrido-Astray MC; Perucho T; Morán-Jiménez MJ; García-Bravo M; Méndez M; Poblete-Gutiérrez P; Frank J; Henriques-Gil N; de Salamanca RE Exp Dermatol; 2010 Aug; 19(8):e326-8. PubMed ID: 20163457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]